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A B S T R A C T   
The metastasis suppressor protein NME1 is an evolutionarily conserved and multifunctional enzyme that plays an 
important role in suppressing the invasion and metastasis of tumour cells. The nucleoside diphosphate kinase 
(NDPK) activity of NME1 is well recognized in balancing the intracellular pools of nucleotide diphosphates and 
triphosphates to regulate cytoskeletal rearrangement and cell motility, endocytosis, intracellular trafficking, and 
metastasis. In addition, NME1 was found to function as a protein-histidine kinase, 3′-5′ exonuclease and geranyl/ 
farnesyl pyrophosphate kinase. These diverse cellular functions are regulated at the level of expression, post- 
translational modifications, and regulatory interactions. The NDPK activity of NME1 has been shown to be 
inhibited in vitro and in vivo under oxidative stress, and the inhibitory effect mediated via redox-sensitive cysteine 
residues. In this study, affinity purification followed by mass spectrometric analysis revealed NME1 to be a major 
coenzyme A (CoA) binding protein in cultured cells and rat tissues. NME1 is also found covalently modified by 
CoA (CoAlation) at Cys109 in the CoAlome analysis of HEK293/Pank1β cells treated with the disulfide-stress 
inducer, diamide. Further analysis showed that recombinant NME1 is efficiently CoAlated in vitro and in 
cellular response to oxidising agents and metabolic stress. In vitro CoAlation of recombinant wild type NME1, but 
not the C109A mutant, results in the inhibition of its NDPK activity. Moreover, CoA also functions as a 
competitive inhibitor of the NME1 NDPK activity by binding non-covalently to the nucleotide binding site. Taken 
together, our data reveal metastasis suppressor protein NME1 as a novel binding partner of the key metabolic 
regulator CoA, which inhibits its nucleoside diphosphate kinase activity via non-covalent and covalent 
interactions.   
1. Introduction 
Nucleoside diphosphate kinases (NDPKs) are multifunctional en-
zymes found in organisms across all domains of life [1]. The NDPKs are 
encoded by the non-metastatic, NME gene family in humans. Currently, 
there are 10 known members of the NME family, which form two groups 
based on sequence homology and conservation of NDPK functionality 
[1]. The members of group I (NME1-4) share 40–88% sequence ho-
mology and possess NDPK activity. Members belonging to group II 
(NME5-10) share only between 6 and 22% sequence homology and 
exhibit little to no NDPK activity [1,2]. 
NME1 is the most widely studied member of this family, mainly 
because of its metastasis suppressor function [3]. NME1 mainly func-
tions to control intracellular nucleotide homeostasis by catalysing the 
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transfer of a phosphate group from nucleoside triphosphates (NTPs), 
mainly ATP, to nucleoside diphosphates (NDPs) by a ping-pong mech-
anism involving the formation of a phosphohistidine intermediate [1]. 
This histidine residue, along with the Kpn-loop and conserved 
nucleotide-binding pocket are defining features of functional NDPK 
enzymes. In addition to the NDPK activity, NME1 was found to function 
as a protein-histidine kinase, 3′-5′ exonuclease and geranyl/farnesyl 
pyrophosphate kinase. Therefore, it is regarded as a moonlighting 
enzyme [2,4]. 
Structure-function studies of native human NME1 revealed a homo- 
hexameric structure stabilized by cross-interaction between the Kpn- 
loop region and the neighbouring C-terminal domain. Furthermore, 
oligomerisation of NME1 into a hexameric structure is required for its 
phosphotransferase activity either towards NDP phosphorylation or 
protein-histidine phosphorylation, and the suppression of tumour 
metastasis [5]. The structure and function of NME1 have been shown to 
be modulated by reactive oxygen species (ROS) via three redox-sensitive 
cysteine residues. Under oxidative stress, an intramolecular disulfide 
bridge between Cys4 and Cys145 is formed and triggers an overall 
conformational rearrangement that destabilizes the hexameric state, 
resulting in the formation of dimers [6,7]. This conformational change 
influences the Kpn-loop region which is essential for hexamerization and 
NDPK activity. Furthermore, NME1 was found to be glutathionylated at 
Cys109 in cells and in vitro, and this modification inhibits its NDPK ac-
tivity [7]. The C109A mutant is resilient to oxidative stress, shows 
constitutively active NDPK activity and suppresses metastatic growth in 
vivo [6,7]. These findings suggest that the function of NME1 is redox 
regulated and may be implicated in redox signalling. 
The expression, subcellular localisation and function of NME1 are 
regulated at various levels, including transcription, translation, post- 
translational modifications and regulatory interactions. Upregulation 
of NME1 gene expression was found in cells upon ligand-induced acti-
vation of glucocorticoid receptor and oestrogen receptor ɑ [8,9]. 
Epigenetic downregulation by means of DNA methylation of CpG islands 
in the promoter region of NME1 has also been reported [10]. The 
cellular level of NME1 protein is regulated via a ubiquitin-dependent 
proteasomal degradation pathway mediated by the E3 Ub Ligase 
FBXO24, or by sequestration to the lysosome [11,12]. A number of 
NME1 binding partners have been identified, including NME2 and 
NME4, small GTPase CDC42, kinase suppressor of Ras, large GTPases 
dynamin 1/2, the GDP-GTP exchange factor TIAM1, DNA repair and 
redox regulation transcriptional factor APAX1, and pro-apoptotic pro-
tease granzyme A [3]. NME1 depends on a diverse range of binding 
partners and regulators to fulfil its roles in regulating not only intra-
cellular nucleotide homeostasis, but also endocytosis, intracellular 
trafficking, cell motility and metastasis [1]. 
NME1 was the first metastasis suppressor gene to be identified and 
subsequent studies revealed around 30 members of this family [13]. In 
contrast to tumour suppressor genes, metastasis dissemination regula-
tors inhibit metastatic dissemination, but not the growth of the primary 
tumour. The anti-metastatic activity of NME1 has been demonstrated in 
cell-based and animal models by various laboratories. These studies 
revealed that: a) stable overexpression of NME1 in highly metastatic cell 
lines results in significant reduction of their metastatic potential in 
xenograft models [14,15]; b) the increase in lung metastases is observed 
in NME1-deficient mice prone to develop hepatocellular carcinoma 
[16]; and c) siRNA-mediated knockdown of NME1 promotes metastatic 
potential in non-invasive cancer cell lines [17]. 
Coenzyme A (CoA) is a low molecular weight thiol, which is pro-
duced in all living cells by an enzymatic conjugation of ATP, pantetheine 
and cysteine [18,19]. The presence of a highly reactive thiol group al-
lows CoA to bind short-, medium- and long-chain carboxylic acids which 
are transported into cells or produced during catabolic and anabolic 
processes. A diverse range of metabolically active CoA thioesters (ace-
tyl-CoA, malonyl-CoA, HMG-CoA among others) are produced in cells to 
drive cellular metabolism, signal transduction and gene expression. The 
levels of CoA and its thioester derivatives are tightly controlled by 
various extracellular and intracellular stimuli, including hormones, 
nutrients, metabolites and oxidative stress [20–23]. The pathogenesis of 
various human diseases has been associated with dysregulated CoA 
biosynthesis and homeostasis, including cardiac hypertrophy, metabolic 
disorders and cancer [24–27]. Inborn mutations in the human genes of 
the CoA biosynthetic pathway have been implicated in the development 
of neurodegeneration (pantothenate kinase 2 and CoA synthase) and 
dilated cardiomyopathy (phosphopantothenoylcysteine synthetase) 
[28–30]. 
The antioxidant function of CoA in redox regulation has been 
recently discovered. CoA was shown to employ its highly reactive thiol 
group for covalent modification of solvent-exposed cysteine residues in 
cellular response to oxidative or metabolic stress. This novel post- 
translational modification (PTM) was termed protein CoAlation and 
shown to be a widespread and reversible mechanism of redox regulation 
[31–37]. To date, more than 2100 proteins have been found to be 
CoAlated in prokaryotic and eukaryotic cells with the use of a mass 
spectrometry-based methodology and highly specific anti-CoA mono-
clonal antibody [35,36,38,39]. Bioinformatic analysis showed that the 
vast majority of CoAlated proteins are involved in metabolic processes, 
as well as the antioxidant response and protein synthesis. Recent studies 
revealed that protein CoAlation regulates the activity, conformation and 
subcellular localisation of modified protein, and protects cysteine resi-
dues from irreversible overoxidation [31–37,40]. 
In this study, we demonstrate for the first time that all four members 
of the Group I NME family of proteins specifically associate with CoA 
affinity matrices during the purification of CoA binding partners from 
mammalian cell and tissue lysates. Furthermore, NME1 was found to be 
among CoAlated proteins in mammalian cells treated with the disulfide- 
stress inducer, diamide. Therefore, our efforts have been focused on 
investigating NME1 CoAlation in vitro and in vivo, and the regulation of 
its NDPK activity by CoA binding. We showed that recombinant NME1 is 
efficiently CoAlated in vitro, and oxidising agents and metabolic stress 
induce covalent modification of NME1 by CoA in cells. Furthermore, the 
NDPK activity of in vitro CoAlated NME1 is inhibited and the inhibition 
is reversed by the reducing agent DTT. We also found that CoA can 
function as a competitive ATP-binding inhibitor of the NME1 NDPK 
activity. Altogether, these findings uncover a novel mode of NME1 
regulation by a key metabolic integrator CoA, which is particularly 
pronounced in cellular response to oxidative or metabolic stress. 
2. Materials and methods 
2.1. Reagents and chemicals 
Unless otherwise stated, all common reagents and chemicals were 
obtained from Sigma-Aldrich, including ATP, CoA monomer, CoA di-
sulfide (CoASSCoA), hydrogen peroxide (H2O2), 2′-deoxycytidine 5′- 
diphosphate sodium salt (dCDP), phosphoenolpyruvate (PEP) pyruvate 
kinase (PK), lactate dehydrogenase (LDH), N-ethylmaleimide (NEM), 
diamide, and coenzyme A (CoA)-agarose. The generation and charac-
terisation of the mouse anti-CoA monoclonal antibody 1F10 has been 
previously described [38]. Other antibodies used were rabbit anti-NME1 
polyclonal antibody (WB dilution 1:3000, Proteintech® Europe); Alexa 
Fluor 680 goat anti-mouse IgG H&L (WB dilution 1:10,000, Life Tech-
nologies) and IRdye 800 CW goat anti-rabbit IgG H&L (WB dilution 
1:10,000, LI-COR Biosciences). 
2.2. Plasmids and mutagenesis 
pTwistCMV-Hygro and pET28a (+) plasmids containing a C-terminal 
Flag-tagged or an N-terminal 6xHis-tagged human NME1 cDNA 
(CR542104.1), respectively, were synthesised by TwistBiosciences. 
hNME1 cDNA sequence within the pET28a (+)-His-hNME1 plasmid was 
codon optimized for protein expression in Escherichia coli BLR (DE3) 
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cells. 
To substitute the Flag-tag with a 6xHis-tag within the pTwistCMV- 
Flag-hNME1 plasmid, the plasmid was amplified using phosphorylated 
primers, one of which contained an overhang with the His-tag sequence. 
After amplification, the PCR product was circularized using T4 DNA 
ligase (Thermo Scientific), and transformed in E. coli Top10 cells. The 
phosphorylated primers used were; Forward primer 5′-P-CATCATCAT-
CATCATCATTGAGGATCCGCAG GCCTCT-3′) and reverse primer 5′-P- 
GCTGCCTTCATAGATCCAGTTCTGAGC-3′). The final sequence of His- 
hNME1 in pTwistCMV-hNME1-His plasmid was confirmed by Sanger 
sequencing. 
To mutate the hNME1 Cys109 residue to an Ala109, site-directed 
mutagenesis was performed as described in the QuickChangeXL site- 
directed mutagenesis protocol (Agilent Technologies). A single point 
mutation was introduced in the pET28a (+)-His-hNME1 plasmid. For-
ward primer 5′-GGTACGATTCGCGGGGATTTCGCTATTCAGGTAG-
GACGC AATATC-3′ and reverse primer 5′- 
GATATTGCGTCCTACCTGAATAGCGAAATCCCCGC GAATCGTACC-3′
were used to generate the pET28a (+)-His-hNME1 C109A mutant 
plasmid. 
2.3. Generation of CoA affinity matrices and affinity purification of CoA- 
binding proteins 
The CoA-sulfolink matrix was generated by coupling the SulfoLink® 
Coupling Resin (Thermo Scientific) to coenzyme A (5 mg CoA/500 μL 
bead-volume) in coupling buffer (50 mM Tris-HCl pH 8.5, 5 mM ethyl-
enediaminetetraacetic acid (EDTA)) by end to end mixing at room 
temperature (RT) for 2 h. Non-specific binding sites on the beads were 
then blocked with 50 mM L-Cysteine-HCl and 25 mM tris(2- 
carboxyethyl)phosphine (TCEP) for 45 min at RT. The CoA-bound 
resins were washed 4 times with 8X bead-volume of 1 M NaCl. 
Finally, the generated CoA-sulfolink beads were washed with 6X bead- 
volume of 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, sup-
plemented with 0.02% sodium azide for storage at 4 ◦C in a 50% sus-
pension. All washes were done by centrifugation at 4 ◦C, 956×g for 2 
min. 
The CoA-agarose and Tris-agarose matrices were regenerated from 
lyophilised beads (Sigma-Aldrich) in 10X bead volume of expansion 
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA). Matrices 
were washed three times with 10X bead-volume of expansion buffer and 
stored in a 50% suspension with supplementation of 0.02% sodium 
azide. 
2.4. Preparation of rat tissue and cell lysates, and affinity purification of 
CoA-binding proteins 
All experiments involving animals were performed in accordance 
with the European Convention for the Protection of Vertebrate Animals 
used for Experimental and Other Scientific Purposes (CETS no.123) and 
the UK Animals (Scientific Procedures) Act 1986 amendment regula-
tions 2012. 
Rat liver, kidney, brain and heart were harvested from 
pentobarbitone-anaesthetised rats (300 mg/kg of body weight) and 
immediately freeze-clamped using tongs pre-cooled in liquid nitrogen 
(N2). Frozen organs were powdered in liquid N2 and homogenised with a 
tissue tearor in ice-cold lysis buffer, which is composed of 50 mM Tris- 
HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 50 mM NaF, 5 mM Na2P4O7, 
and 1% Triton X-100, supplemented with 100 mM NEM and 1X cOm-
plete Mini protease inhibitor cocktail (PIC, Roche). Tissue lysates were 
centrifuged at 53,000×g (Beckman JA-25.50 rotor) for 5 min at 4 ◦C. 
The supernatant was used for affinity purification of CoA-binding 
proteins. 
~2 million HEK293/Pank1β cells were seeded onto 100 mm plates. 
To induce diamide stress, cells were treated at 37 ◦C with 500 μM 
diamide for 30 min or treated and left to recover in full Dulbecco’s 
Modified Eagle Medium (DMEM) for another 30 min. Cells were har-
vested by pressure washing and centrifuged at 1800×g for 5 min at RT. 
Cells were lysed with 500 μL of lysis buffer supplemented with 100 mM 
NEM and 1X PIC, and incubated on ice for 20 min before centrifugation 
at maximum speed for 15 min at 4 ◦C. The supernatant was used for 
affinity purification of CoA-binding proteins. 
To pull-down CoA-binding proteins from rat tissues and HEK293/ 
Pank1β cells, prepared lysates were divided into 3 equal parts and first 
incubated with 20 μL Tris-agarose (50% suspension) for 18 h at 4 ◦C by 
end to end mixing. The supernatant was collected and further incubated 
with 20 μL Tris-agarose, or CoA-agarose or CoA-sulfolink matrices for 3 
h at 4 ◦C. After incubation, beads were washed three times with lysis 
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 50 mM NaF, 
5 mM Na2P4O7, and 1% Triton X-100) by centrifugation (956×g, 2 min, 
4 ◦C). Bound proteins were released from beads through boiling in 
sodium-dodecyl-sulphate (SDS) loading buffer (1x) for 5 min and ana-
lysed by SDS-PAGE under reducing conditions. 
2.5. Mammalian cell culture, transfection and treatment with oxidising 
agents and metabolic stress 
HEK293/Pank1β cells stably overexpressing pantothenate kinase 1β 
(HEK293/Pank1β) were generated as previously described [35]. 
HEK293/Pank1β cells were maintained in DMEM supplemented with 
10% foetal bovine serum (FBS, Gibco), 50 U/mL penicillin and 0.25 
μg/mL streptomycin (Lonza). Cells were cultured at 37 ◦C and 5% CO2. 
Approximately 0.6 million HEK293/Pank1β cells were seeded onto 
60 mm plates and transiently transfected at ~60% confluency with 
TwistCMV-6xHis-hNME1 plasmid using TurboFect reagent (Thermo 
Scientific), according to the manufacturer’s protocol. Transfected cells 
were grown for 24 h in complete DMEM with 10% FBS. To prime cells 
for oxidative stress, the medium was replaced with glucose- and 
pyruvate-free DMEM supplemented with 5 mM glucose and 10% FBS 
and cells were incubated for another 24 h. Cells were then treated at 
37 ◦C with diamide (500 μM–30 min) or H2O2 (100 μM, 500 μM, 1 mM, 
2.5 mM–30 min). To induce metabolic stress, the media of cells were 
changed to glucose- and pyruvate-free DMEM for 20 h. Cells were har-
vested by pressure washing and centrifuged at 1800×g for 5 min at room 
temperature (RT). Cells were lysed with 300 μL of lysis buffer supple-
mented with 100 mM NEM and 1X PIC, and incubated on ice for 20 min 
before centrifugation at maximum speed for 15 min at 4 ◦C. The su-
pernatant was used for SDS-PAGE analysis or affinity purification to 
pull-down His-NME1 by end-to-end mixing of cell lysate with Super 
Nickel NTA (Ni-NTA) resin (10 μL beads/ 0.5 mg protein, Generon) at 4 
◦C overnight. 
2.6. Exposure of bacterial cells to oxidising agents or nutrient deprivation 
Escherichia coli BL21 (DE3) cells were transformed with the pET28a 
(+)-His-hNME1 plasmid. Cells were cultured in LB medium at 37 ◦C to 
mid-log phase (OD600 = 0.7) and the expression of His-hNME1 was 
induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 
3 h at 25 ◦C. Oxidative stress was then induced by culturing bacteria for 
10 min at 37 ◦C with 2 mM diamide, or 10 mM H2O2. To induce hy-
pochlorite (NaOCl) stress, the IPTG-induced bacterial culture was pel-
leted, resuspended in warm M9 minimal media (M9), and incubated for 
5 min at 37 ◦C, before the 10 min-treatment with 100 μM NaOCl. Cells 
were lysed with bacterial lysis buffer (50 mM Tris-HCl pH 7.5, 50 mM 
NaCl, 50 mM NaF, 5 mM Na2P4O7) freshly supplemented with 25 mM 
NEM, 0.1 mg/ml lysozyme and 1X PIC. The lysates were incubated on 
ice for 20 min and mixed with an equal volume of 2% SDS, sonicated on 
ice in the Soniprep 150 over 5 cycles of 5 s pulse ON and 20 s pulse OFF 
to reduce viscosity and centrifuged at 21,000×g for 20 min at 4 ◦C. The 
supernatant was mixed with non-reducing loading buffer and heated at 
95 ◦C for 5 min. His-hNME1 was pulled-down from the supernatant 
using TALON affinity resin (Generon) and analysed together with total 
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cell lysates by SDS–PAGE under non-reducing condition and Western 
blotting with anti-CoA antibody. 
2.7. Expression and purification of 6XHis-hNME1 wild type (WT) and 
C109A mutant 
A single colony of Escherichia coli BLR (DE3) cells containing pET28a 
(+)-His-hNME1 or pET28a (+)His-hNME1 C109A mutant plasmid was 
grown overnight in Luria Broth (LB, Miller) supplemented with 25 μg/ 
mL kanamycin. The preculture was diluted 1:100 in 1 L LB medium and 
grown at 37 ◦C until an OD600 of 0.7 was reached. After induction with 
0.5 mM IPTG, the cells were grown for 18 h at 25 ◦C. The cells were 
harvested by centrifugation (15 min at 6200×g, at 4 ◦C; Beckman JLA 
8.1000 rotor). The pellet was resuspended in 50 mM Tris-HCl pH 7.5, 
500 mM NaCl, 1 mM β-mercaptoethanol, 50 μg/mL DNase I and 10 mM 
MgCl2, supplemented with 1X PIC and sonicated on ice in the Soniprep 
150 over 15 cycles of 15 s pulse ON and 30 s pulse OFF at 4 ◦C. Following 
sonication, the samples were centrifuged at 39,000×g at 4 ◦C for 30 min 
(Beckman JA-25.50 rotor). The cell lysate was loaded onto a Xk16/20 
column (GE Healthcare) packed with TALON affinity resin (Generon), 
equilibrated in 50 mM Tris-HCl pH 7.5, 500 mM NaCl, 1 mM β-mer-
captoethanol, and 10 mM MgCl2. With an ÄKTA™start system (GE 
Healthcare), the protein was eluted using a linear gradient to 0.25 M 
imidazole in the same buffer. His-hNME1 WT and C109A were dialysed 
to 50 mM Tris-HCl pH 7.5, 500 mM NaCl, 10 mM MgCl2 and 2 mM 
dithiothreitol (DTT). Proteins were stored in 10% glycerol at − 20 ◦C 
until use. 
2.8. In vitro CoAlation of His-hNME1 WT and C109A mutant 
Purified recombinant His-hNME1 WT and C109A mutant were 
reduced with 20 mM DTT for 30 min at 25 ◦C. Micro Bio-SpinTM6 col-
umns (Bio-Rad) were used to remove excess DTT. NME1 CoAlation assay 
was performed in nitrogen (N2)-flushed assay buffer composed of 20 mM 
Tris-HCl pH 8.0, and 100 mM NaCl. Reduced His-hNME1 WT or C109A 
(100 μM) was incubated with CoA (400 μM) in the presence and absence 
of CoA dimer (CoASSCoA, 400 μM) for 1.5 h at 25 ◦C. For oxidising 
conditions, recombinant proteins were incubated with CoA (700 μM) for 
5 min and a further 1 h and 25 min in the presence of H2O2 (2 mM). The 
reactions were stopped by passing the reaction mixture through a Micro 
Bio-Spin™ 6 column to remove excess CoA, CoASSCoA or H2O2. NME1 
CoAlation was confirmed by Western blotting with anti-CoA antibodies. 
Samples were used in further NDPK activity assays. For Western blotting 
or Coomassie-stain analysis of in vitro NME1 CoAlation, samples were 
incubated with 100 mM NEM for 10 min at 25 ◦C and boiled in 1x SDS 
loading buffer in the presence or absence of 100 mM DTT for 5 min at 
95 ◦C. 
2.9. Western blot analysis 
The concentration of protein lysates from rat tissue lysates and 
HEK293/Pank1β were measured using the Bicinchoninic acid assay 
(BCA, Thermo Scientific). Samples were mixed with SDS loading buffer 
(1X) in the presence or absence of DTT, and boiled for 5 min. 20 μg of 
protein lysates (rat tissues or HEK293/Pank1β) or 0.5 μg of recombinant 
NME1 WT and C109A mutant were separated by SDS-PAGE in a 4–20% 
Precast Gel (Sigma-Aldrich) and subsequently transferred to a low- 
fluorescence PVDF membrane (Merck, Millipore). Following transfer, 
the membrane was blocked with Intercept® (TBS) Protein-Free blocking 
buffer (LI-COR Biosciences) for 20 min at RT. The PVDF membrane was 
subsequently incubated with mouse anti-CoA primary antibodies 
(1:6000) or rabbit anti-NME1 primary antibodies (1:3000, Proteintech) 
at 4 ◦C overnight or 2 h at RT. The membranes were washed extensively 
with Tris-buffer saline supplemented with 0.05% Tween 20 (TBSt) 
before incubation with the secondary anti-mouse (1:10,000) and anti- 
rabbit antibodies (1:10,000) for 30 min at RT. The immunoreactive 
bands were visualised using Odyssey Scanner CLx and analysed with 
Image Studio Lite software (LI-COR Biosciences). 
2.10. NDPK activity assay 
The assay was performed as described previously [41,42]. In brief, 
the NDPK activity assay was carried out in a 200 μL reaction mixture in a 
BRAND® 96-well plate (Sigma-Aldrich), containing 250 μM NADH 
(Grade II, purity >98%, Roche), 2.5 U LDH, 2 U PK, 0.2 mM dCDP, 2 mM 
ATP and 0.3 mM PEP. The reaction was initiated by the addition of 25 
nM His-hNME1 WT or C109A mutant. The CoAlated samples of NME1 
were prepared via incubation with CoA and CoASSCoA as described in 
section 2.8. and the reaction was stopped by buffer exchange using the 
Micro Bio-SpinTM6 columns. The absorbance values at 340 nm were 
measured at 10 s intervals over a period of 5 min using the FLUOstar 
OPTIMA microplate reader. Specific NDPK activity was calculated with 
the following equation (Equation (1)); where the extinction coefficient 
of NADH is ϵ = 6220 M− 1cm− 1, l represents the pathlength (0.222 cm), 
ΔAbs340Sample represents the change in absorbance at 340 nm of sam-





















The NDPK activity was measured from at least three independent 
replicates. The values of specific NDPK activity were subsequently 
converted to percentage NDPK activity (%) by comparing to the reduced 
NME1 WT and NME1 C109A activity. For statistical analysis, a Šidák 
multiple comparison, ordinary one-way ANOVA test was used assuming 
unequal variances with GraphPad Prism (Version 9.1.0). The statistical 
significance established have been indicated in the figure legends with p 
values defined and the statistical variability was estimated with the 
standard error of the mean (SEM). 
2.11. NDPK activity inhibition assay 
The NDPK activity assay of NME1 WT and C109A mutant were 
performed as described in section 2.10, with the exception of the addi-
tion of increasing concentrations of CoA (0, 2, 4 mM) within the reaction 
mixture. The NDPK activity was measured from at least three indepen-
dent replicates. The values of specific NDPK activity were subsequently 
converted to percentage NDPK activity (%) by comparing to the reduced 
NME1 WT and NME1 C109A activity. 
2.12. Mass spectrometry and data processing 
2.12.1. Trypsin digestion and Nudix7 cleavage 
Liquid Chromatography-mass spectrometry (LC-MS/MS) identifica-
tion of CoAlated peptides from diamide-treated HEK293/Pank1β cells 
(Supplementary Table 1) and excised gel bands of 17 kDa (Fig. 1C and D) 
was carried out as previously described [35]. Excised gel bands were 
destained with acetonitrile (MeCN), and alkylated with 50 mM iodoa-
cetamide (IAM) in 50 mM ammonium bicarbonate (pH 7.8), in the dark 
at RT. Gel bands were digested overnight with 7 ng/μL of trypsin 
(Promega, UK) in 50 mM ammonium bicarbonate, 5 mM IAM, at 37 ◦C. 
Peptides were extracted initially with 2% formic acid (FA), followed by 
30% MeCN/0.5% FA. Prior to LC/MS analysis, the combined peptide 
mixtures were partially dried down in a Speed Vac (Savant, Fischer 
Scientific) to remove the MeCN. Proteins from diamide-treated 
HEK293/Pank1β lysates were precipitated with 90% methanol 
(− 20 ◦C) by vortexing and pelleted by centrifugation at 5000×g for 20 
min at 4 ◦C. The protein pellet was homogenised for 30 s at RT in 1.5 mL 
of 90% methanol with a tissue tearor to remove free CoA, CoA esters, 
LMW thiols, and adenine nucleotides. 50 μL of the homogenate was 
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aliquoted and resolubilised with 100 mM Tris-HCL pH 7.5, 5 mM EDTA, 
0.5% SDS, 6 M urea to determine the protein concentration using BCA 
assay. The remaining homogenate was centrifuged at 18,000×g for 3 
min at RT before partial-drying with a Speed Vac for 6 min. The protein 
pellet was digested for 90 min at 30 ◦C with enzyme/protein ratio 1:200 
of LysC (mass-spec grade, Promega, UK) in 50 mM ammonium bicar-
bonate supplemented with 6.4 mM IAM and further digested with 7 
ng/μL of trypsin at 30 ◦C for 10 h. The trypsinised samples were 
heat-inactivated, followed by the incubation with anti-CoA monoclonal 
antibodies, which were cross-linked to Protein G-Sepharose. Immuno-
precipitated peptides were eluted from beads with 0.1% trifluoroacetic 
acid and dried completely in a speed vac concentrator. The resulting 
pellet was resolubilised in 20 μL of 50 mM ammonium bicarbonate. 2.3 
μL of 50 mM MgCl2 and 1 μL of Nudix 7 (1.7 μg) were added and 
incubated at 37 ◦C for 30 min. The peptide mixtures were acidified and 
desalted using home-made C18 (3 M Empore) stage tip that contained 
1.5 μL of poros R3 (Applied Biosystems) resin. Bound peptides were 
eluted sequentially with 15 μL 30%, 50% and 80% acetonitrile in 0.5% 
FA, and partially dried down to less than 10 μL. Then, 100 μL of Iron 
(III)-immobilized metal ion affinity chromatography (IMAC) binding 
buffer (30% acetonitrile/0.25 M acetic acid) was added to the samples, 
ready for IMAC enrichment. 
2.12.2. Iron (III)-immobilized metal ion affinity chromatography (IMAC) 
enrichment 
PhosSelect iron affinity gel (IMAC, Sigma Aldrich, cat. P9740) beads 
were washed three times with 100 μL of IMAC binding buffer and pre-
pared as 50% slurry. 15 μL were added to the samples and incubated at 
room temperature for 45 min, with vigorous shaking. The beads were 
transferred to a home-made C8 (3 M Empore, USA) stage tip and washed 
4 times with 30 μL binding buffer. Bound peptides were eluted 
sequentially with 30 μL of 500 mM imidazole pH 7.6, 30% MeCN/500 
mM imidazole pH 7.6 and 50% MeCN/0.5% FA. The combined eluates 
were acidified, partially dry down in a Speed Vac and desalted using 
home-made C18 (3 M Empore, USA) stage tip that contained 0.8 μL of 
poros R3 (Applied Biosystems, UK) resin. Bound peptides were eluted 
sequentially with 30%, 50% and 80% acetonitrile in 0.5% FA, and 
partially dried down, ready for MS analysis. 
2.12.3. LC-MS/MS analysis 
Peptide mixtures were separated by nano-scale capillary LC-MS/MS 
using an Ultimate U3000 HPLC (ThermoScientific Dionex, San Jose, 
USA) to deliver a flow of approximately 300 nL/min. A C18 Acclaim 
PepMap100 5 μm, 100 μm × 20 mm nanoViper (ThermoScientific 
Dionex, San Jose, USA), trapped the peptides prior to separation on a 
C18 Acclaim PepMap100 3 μm, 75 μm × 250 mm nanoViper (Ther-
moScientific Dionex, San Jose, USA). The column was developed with an 
acetonitrile gradient, consisting of buffer A (2% MeCN, 0.1% formic 
acid) and buffer B (80% MeCN, 0.1% formic acid). Peptides from solu-
tion digests were eluted using a gradient of 3 to 10% B in 49 min, 
10–35% in 70 min and 35–90% in 7 min, while gel bands digest were 
eluted with a gradient of 6–45% B in 31 min and 45–90% B in 15 min. 
The analytical column outlet was directly interfaced via a nano-flow 
electrospray ionisation source, with a hybrid quadrupole orbitrap 
mass spectrometer either a Velos (solution digest) or Q Exactive Plus (gel 
bands digest) (ThermoScientific, San Jose, USA). The Velos mass spec-
trometer was operated in standard data dependent mode, performing 
survey full-scans (m/z 3500–1600) with a resolution of 60,000 at m/z =
400, followed by MS2 acquisitions of the 20 most intense ions in the LTQ 
ion trap. The Q Exactive plus mass spectrometer was also operated in 
data dependent mode, performing MS1 full scans (m/z = 380–1600) 
with a resolution of 70,000, followed by MS2 acquisitions of the 15 most 
intense ions with a resolution of 17,500. 
2.12.4. MaxQuant (MQ) identification of CoAlated peptides 
For solution digested samples, the acquired MS/MS raw files were 
processed using MaxQuant [43] with the integrated Andromeda search 
engine (v.1.5.2.8) as standard LC/MS identification. MS/MS spectra 
were searched against a Human UniProt Fasta database. Carbamido-
methylation, N-ethylmaleimide, CoA_765, CoA_356 and CoA_338 of 
cysteines, and oxidation of methionine were set as variable modifica-
tions. Enzyme specificity was set to trypsin, with a maximum of two 
missed cleavages allowed. CoAlated peptides identified were filtered 
using default settings of a minimum score of 40 for accepting an MS/MS 
identification for modified peptides. The Andromeda score (Scores, 
Supplementary Table 1) is calculated as ~10 times the logarithm of the 
probability of matching at least k out of the n theoretical masses by 
chance, where k = number of matching ions in a spectrum and n = total 
number of theoretical ions. The default score of a minimum of >40 was 
applied, hence, scores higher than 40 are considered confident 
assignments. 
For gel bands, the acquired raw data files were searched using 
Mascot (Matrix Science, v2.4) against a Human and Rat UniProt Fasta 
database. Up to two missed cleavages were allowed for a trypsin digest 
search. Variable modifications were set as carbamidomethylation of 
cysteines, N-terminal protein acetylation and oxidation of methionine. 
Scaffold (version 4.8.4, Proteome Software Inc.) was used to validate 
MS/MS-based peptide and protein identifications. The Normalised Total 
Spectral Count in Table 1 is determined in Scaffold by a) finding the total 
number of spectra in each BioSample. b) The average number of spectra 
across all BioSamples is calculated. c) Scaffold then multiplies each 
spectrum count by the average over the total for each BioSample. 
3. Results 
3.1. Affinity purification and mass spectrometric analysis of CoA-binding 
proteins 
The presence of an ADP moiety and a pantetheine tail with a highly 
reactive thiol group allows CoA to be involved in diverse biochemical 
reactions and regulatory interactions. Many CoA-binding proteins have 
been identified and their mode of interaction have been investigated 
using biochemical, biophysical, and crystallographic approaches [44]. 
The identified interactions were found to occur via non-covalent and 
dynamic covalent bonds [33,44]. In this study, we searched for novel 
CoA-binding proteins in rat tissues and cultured cells using two affinity 
matrices, which have CoA immobilized either via the thiol group 
(CoA-sulfolink) or the amino group of the ADP moiety (CoA-agarose) 
(Fig. 1A). The orientation of CoA immobilisation to the agarose beads 
provides a strategy for the affinity purification of proteins that can 
recognise either a free 3′,5′-ADP moiety or a pantetheine tail with a free 
thiol (-SH) group, respectively. To eliminate proteins which bind 
non-specifically to the matrix, Tris-agarose beads were used as a control 
(Fig. 1A). 
Initially, all three matrices were incubated with lysates from rat 
tissues (heart, brain, liver and kidney). After extensive washes, bound 
proteins were denatured and separated by SDS-PAGE under reducing 
conditions. The analysis of the Coomassie-stained gel revealed distinc-
tive patterns of proteins bound to respective matrices. A number of 
proteins were associated with CoA-agarose and/or CoA-sulfolink 
matrices, but not with Tris-agarose (Fig. 1B). A protein of approxi-
mately 17 kDa was notably detectable in CoA-agarose samples from all 
analysed rat tissues, when compared to control Tris-agarose beads. A 
protein with a similar molecular weight was also bound to the CoA- 
sulfolink affinity matrix, but with lower efficacy. 
To validate and further extend these findings, we used HEK293 cells 
with stable overexpression of pantothenate kinase 1β (HEK293/ 
Pank1β). This cell line was shown to produce approximately six times 
more CoA than parental HEK293 cells, which is comparable to the level 
of CoA found in rat tissues (heart, liver and kidney) and primary car-
diomyocytes [35]. To examine the effect of oxidative stress on the 
pattern of CoA-binding proteins, affinity matrices were incubated with 
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the lysates of exponentially growing HEK293/Pank1β cells (control), 
cells treated with 500 μM diamide for 30 min (diamide-stressed) or cells 
recovered from the diamide-induced stress in fresh DMEM media for 30 
min (stress-recovered). The analysis of Coomassie-stained gel suggests 
an enrichment of proteins from HEK293/Pank1β cells bound to 
CoA-agarose matrix, compared to CoA-sulfolink or Tris-agarose matrices 
(Fig. 1C). Reduced binding to CoA-agarose matrix is detected in 
diamide-stressed cells, when compared to exponentially growing cells, 
but this observation requires further validation. Similar to the rat tissue 
lysates, a band of approximately 17 kDa from HEK293/Pank1β cell ly-
sates was readily detected in both CoA affinity matrices but absent from 
the control Tris-agarose matrix. In contrast, the observed 17 kDa protein 
binds with a similar efficacy to both CoA-agarose and CoA-sulfolink 
affinity matrices in HEK293/Pank1β cell lysates (Fig. 1C). 
To identify this abundant CoA-binding protein, gel slices of 
Coomassie-stained bands, corresponding to the 17 kDa protein from rat 
heart tissue and stress-recovered HEK293/Pank1β cells were processed 
for mass spectrometric analysis. The LC-MS/MS analysis of tryptic 
peptides from the rat heart tissue and HEK293/Pank1β cells identified 
NME1 (NDPKA) and NME2 (NDPKB) as the two most abundant proteins 
present based on the normalised total spectral count [45], (>95% con-
fidence level) (Table 1). In addition, the other two isoforms of Group I 
NMEs: NME3 (NDPKC) and NME4 (NDPKD), were also identified albeit 
with a lower abundance. These findings suggest that all four members of 
the Group I NME family (NME1-4) are CoA-binding proteins and that 
their interaction with CoA is possibly mediated via their nucleotide 
binding pocket. The normalised total spectrum count which represents 
protein abundance for all 4 NME isoforms is shown in Table 1. The 
multiple sequence alignment of NME1-4 is shown in Supplementary 
Fig. 1. 
3.2. NME1 is CoAlated at Cys109 in cellular response to oxidative stress 
Recent studies from our laboratory demonstrated widespread protein 
CoAlation in mammalian cells and tissues exposed to oxidative or 
metabolic stress [36]. Using an optimized MS-based methodology, 
numerous CoAlated proteins have been identified from H2O2-perfused 
rat heart, liver mitochondria of 24 h-starved rats and H2O2-treated 
Fig. 1. SDS-PAGE analysis of CoA-binding pro-
teins from rat tissue and HEK293/Pank1β cell 
lysates. (A) Schematic diagrams of affinity matrices 
used in this study: Tris-agarose control beads [C], 
CoA-agarose [A] and CoA-sulfolink [S]. (B) Lysates 
of rat liver, kidney, brain and heart tissues were 
incubated with affinity matrices, bound proteins 
separated by SDS-PAGE and visualised by Coo-
massie staining; (C) Lysates of untreated, diamide- 
treated (500 μM) or stress-recovered HEK293/ 
Pank1β cells were probed with affinity matrices and 
the bound proteins were separated by SDS-PAGE, 
and visualised by Coomassie staining. The arrows 
indicate a ~17 kDa protein which binds specifically 
to both CoA-affinity matrices, when compared to 
control beads. The figures shown are indicative of at 
least three independent repeats.   
Table 1 
NME1-4 are identified by LC-MS/MS analysis as CoA-binding proteins. The normalised total spectrum count refers to the total spectra established for a single protein.  
HEK293/Pank1β cells 
Protein Accession number Molecular weight (kDa) Subcellular localisation Normalised 
Total spectral count 
NME1 (NDPKA) NDKA_HUMAN (P15531) 17 Cytoplasm 
Plasma membrane 
411 
NME2 (NDPKB) NDKB_HUMAN (P22392) 17 Cytoplasm 
Midbody ring 
395 
NME3 (NDPKC) NDK3_HUMAN (Q13232) 19 Nucleoplasm 
Cytoplasm 
13 
NME4 (NDPKD) NDKM_HUMAN (O00746) 21 Mitochondria 15 
Rat heart 
Protein Accession number Molecular weight (kDa) Subcellular localisation Normalised Total spectral count 
NME1 (NDPKA) NDKA_RAT (Q05982) 17 Cytoplasm 
Plasma membrane 
623 
NME2 (NDPKB) NDKB_RAT (P19804) 17 Cytoplasm 
Midbody ring 
855 
NME3 (NDPKC) Q99NI1_RAT (Q99NI1) 19 Nucleoplasm 
Cytoplasm 
17 
NME4 (NDPKD) D3ZMT9_RAT (D3ZMT9) 21 Mitochondria 10  
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HEK293/Pank1β cells [36]. The extensive protein CoAlation detected in 
diamide-treated HEK293/Pank1β cells prompted us to determine the 
identity of CoA-modified proteins (Fig. 2A) [36]. Diamide-treated 
HEK293/Pank1β cells were lysed, CoAlated peptides enriched and 
identified by LC-MS/MS. The MS analysis revealed 498 CoAlated pep-
tides, corresponding to 402 proteins (Supplementary Table 1). Bio-
informatic pathway analysis of identified CoAlated proteins showed that 
they are predominantly involved in metabolic pathways, as well as stress 
response processes and protein synthesis. In the list of CoAlated pro-
teins, a peptide corresponding to NME1 was found to be CoA-modified 
(Supplementary Table 1). Fig. 2B shows the LC-MS/MS spectrum of a 
peptide derived from NME1 (GDFCIQVGR) with an increase in 356 Da at 
cysteine 109 (Cys109), which corresponds to the covalent attachment of 
4-phosphopantetheine (a product of CoA cleavage by Nudix7 hydro-
lase). Cys109 is located in the Kpn-loop of NME1 and is in close vicinity 
to the active site (Fig. 2C). Through cooperative interactions with the 
C-terminal region of NMEs, the Kpn-loop is important in maintaining the 
oligomeric stability of the enzymatically active hexamer, and hence is 
crucial for NDPK activity [46]. NME1 is known to be the target for 
different oxidative post-translational modifications at Cys109, including 
sulfenylation, sulfonylation, intermolecular disulfide bonding and glu-
tathionylation [7]. Therefore, Cys109 was proposed to function as a 
redox-sensitive switch in regulating the function of NME1 under 
oxidative stress [7]. Interestingly, Cys109 is conserved in NME1-3, but 
not in the mitochondrially localised NME4 (Fig. 2D and S1). 
3.3. NME1 is CoAlated in vitro and in bacterial cells exposed to oxidative 
stress and nutrient deprivation 
To validate and further investigate the mode of CoA binding to 
NME1, we examined CoAlation of recombinant hNME1 in vitro and in 
cells exposed to oxidative or metabolic stress. Initially, our efforts were 
focused on testing covalent modification of NME1 by CoA using an in 
vitro CoAlation assay. To do so, recombinant hNME1 was in vitro 
CoAlated in the presence of CoA and CoA disulfide (CoASSCoA) or CoA 
and H2O2 for 1.5 h at 25 ◦C. The reaction was stopped by the addition of 
10 mM NEM. The samples were separated by SDS-PAGE gel and either 
analysed by Western blotting with anti-CoA and anti-NME1 antibodies 
or Coomassie staining (Fig. 3A). The Coomassie-stained gel and anti- 
NME1 Western blot show that recombinant His-hNME1 migrates on 
the SDS-PAGE gel as a ~20 kDa band under reducing and non-reducing 
conditions (Fig. 3A). The anti-CoA Western blot showed that hNME1 
CoAlation did not occur in the presence of only reduced CoA (control 
sample - Lane 1), but was induced with the addition CoASSCoA (Lane 2) 
or H2O2 and CoA (Lane 3). Only weak anti-CoA immunoreactive bands 
were detected in samples separated under reducing conditions (Fig. 3A, 
WB: anti-CoA, Lanes 4–6). The incubation of hNME1 with CoASSCoA 
induced the formation of NME1 dimers, which were detected on 
Coomassie-stained gel and anti-NME1 Western blot (Fig. 3A, Lane 2), 
possibly mediated through thiol-disulfide exchange. The anti-CoA 
Western blot of NME1 treated with CoASSCoA shows CoAlation of 
both the monomeric and dimeric forms of NME1, but the former being 
the most prominent (Lane 2). The NME1 sample treated with H2O2, in 
the presence of CoA, shows immunoreactive bands which correspond to 
monomeric, dimeric and oligomeric forms of NME1, and are only 
observed under non-reduced conditions (Fig. 3A, WB: anti-CoA – Lane 
3). Notably, a faster migrating band of ~17 kDa was detected when 
hNME1 was incubated with CoA and H2O2 (Fig. 3A, Lane 3). This faster 
migrating band which is also covalently modified by CoA could corre-
spond to hNME1 with an intramolecular disulfide bond between Cys4 
and Cys145, as previously observed [6]. 
The analysis of hNME1 CoAlation in bacteria was carried out in BL21 
(DE3) cells transformed with the pET28a (+)-His-hNME1 plasmid. 
Oxidative stress was then induced by culturing IPTG-induced bacteria 
for 10 min with 2 mM diamide, or 10 mM H2O2. To stimulate hypo-
chlorite (NaOCl) stress, the IPTG-induced bacterial culture was pelleted, 
resuspended in warm M9 minimal media (M9), and incubated for 5 min 
at 37 ◦C, before the 10 min-treatment with 100 μM NaOCl. hNME1 was 
Fig. 2. hNME1 is CoAlated at its redox-sensitive 
Cys109 in diamide-treated HEK293/Pank1β 
cells. (A) Anti-CoA Western blot reveals extensive 
modification of cellular proteins by CoA in 
HEK293/Pank1β cells treated with 500 μM diamide 
for 30 min, when compared to untreated cells; (B) 
The LC-MS/MS spectrum of the peptide 
(GDFC109IQVGR) corresponding to NME1, con-
taining CoA-modified cysteine (C+356) at residue 
109 was obtained as described in Methods from 
HEK293/Pank1β cells treated with diamide. Frag-
ment ions are coloured cyan and red for y- and b- 
ions, respectively. The asterisks (*) denote the loss 
of phosphoric acid (− 98 Da) from the precursor 
and/or product ions that contained the CoA- 
modified cysteine residue. (C) The X-ray crystal 
structure of hNME1 (PDB: 2HVD) is shown. The 
nucleotide binding pocket is indicated by a red el-
lipse, catalytic histidine residue (His118) in yellow 
and cysteine residues (Cys4, Cys109 and Cys145) in 
orange. The Kpn-loop (residues 89–114) is coloured 
in cyan. (D) The multiple sequence alignment of 
NME1-4 from residues 89 to 120 is shown. The 
redox-sensitive cysteine 109 is shown in orange, 
and conserved catalytic histidine 118 in yellow. The 
Kpn-loop (residues 89–114) of NME is shown in 
cyan. The residue numbering is based on the amino 
acid sequence of NME1. (For interpretation of the 
references to colour in this figure legend, the reader 
is referred to the Web version of this article.)   
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pulled-down from lysed cells using Ni-NTA beads and analysed together 
with total cell lysates by SDS–PAGE under non-reducing condition and 
Western blotting with anti-CoA antibody (Fig. 3B and C). Anti-CoA 
Western blot analysis of total cell lysates shows that diamide induces 
strong protein CoAlation, while a weaker immunoreactive signal is 
observed in samples of H2O2- and NaOCl-treated cells (Fig. 3B). Back-
ground immunoreactivity is detected in control samples and in cells 
cultured in minimal media for 10 min. Immunoblotting of pulled-down 
hNME1 with anti-CoA antibody showed several immunoreactive bands 
in cells exposed to oxidative stress, which correspond to monomeric, 
dimeric and oligomeric forms of NME1 (Fig. 3C). In contrast to controls, 
H2O2- and NaOCl-treated cells, the bulk of pulled-down hNME1 from 
cells exposed to diamide stress migrates around 40 kDa. This immuno-
reactive band corresponds to a major Ponceau-stained band on the 
Western blot membrane and represents the dimeric form of hNME1. A 
weak anti-CoA immunoreactive signal, corresponding to monomeric 
and dimeric forms of NME1 is also observed in cells deprived of glucose 
(M9) for 10 min. A background CoAlation of hNME1 is detected in un-
treated control cells. 
3.4. NME1 is CoAlated in cellular response to oxidative and metabolic 
stresses in HEK293/Pank1β cells 
Further analysis of NME1 CoAlation under oxidative or metabolic 
stress was carried out in mammalian cells. Here, HEK293/Pank1β cells 
were transiently transfected with the pTwist-CMV-His-hNME1 plasmid 
which drives the expression of hNME1. Transfected cells were treated 
with or without 500 μM diamide or subjected to a H2O2 dose-course to 
induce oxidative stress. Ni-NTA beads were used to pull down tran-
siently overexpressed hNME1. Pulled-down hNME1 was separated by 
SDS-PAGE gel under non-reducing conditions and analysed by anti-CoA 
Western blotting (Fig. 4A). Western blot with anti-CoA of pulled-down 
samples showed readily detectable hNME1 CoAlation in cells treated 
with diamide (Fig. 4A) and a dose-dependent increase in H2O2-treated 
cells but not in the control untreated cells (Fig. 4B). 
CoA functions as a key metabolic cofactor in all living cells, and 
therefore, we examined hNME1 CoAlation in mammalian cells under 
metabolic stress (Fig. 4C). In this study, HEK293/Pank1β cells were 
transiently transfected with pTwist-CMV-His-hNME1 plasmid and sub-
jected to glucose deprivation upon 20 h incubation in 5 mM glucose and 
pyruvate-free DMEM media. Harvested cells were lysed and hNME1 was 
Fig. 3. NME1 is CoAlated in vitro and in cellular 
response to oxidative and metabolic stress. (A) 
In vitro CoAlation of recombinant hNME1. In vitro 
CoAlation of 100 μM hNME1 was carried out in the 
presence of 400 μM CoASH; 400 μM CoASSCoA; or 
700 μM CoASH and 2 mM H2O2. After buffer ex-
change, approximately 2 μg recombinant protein 
from each reaction was separated on SDS-PAGE gel 
under reducing (with DTT) or non-reducing condi-
tions (without DTT). Gels were immunoblotted with 
anti-CoA or anti-NME1 antibodies or stained with 
Coomassie Blue. (B, C) CoAlation of hNME1 over-
expressed in E. coli is strongly induced by oxidising 
agents, but weakly under glucose deprivation. The 
expression of hNME1 in E. coli transformed with 
pET28a (+)-hNME1 plasmid was induced with 0.5 
mM IPTG for 18 h at 25 ◦C. Then, bacterial cultures 
were treated with 2 mM diamide, 10 mM H2O2 or 
100 μM NaOCl (in M9 media) for 10 min, or incu-
bated in M9 medium for 10 min. Total bacterial 
lysates (B) and Ni-NTA Sepharose pulled-down 
samples (C) were separated by SDS-PAGE gel 
under non-reducing condition and immunoblotted 
with anti-CoA antibody. Monomers (M), dimers (D) 
or oligomers (O) of NME1 have been indicated. The 
Ponceau-stained membranes show the loading 
control. The figures shown are indicative of three 
independent repeats. (For interpretation of the ref-
erences to colour in this figure legend, the reader is 
referred to the Web version of this article.)   
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pulled-down using Ni-NTA beads. Total cell lysates and pulled-down 
samples were separated by SDS-PAGE gel under non-reducing condi-
tions and immunoblotted with anti-CoA and anti-NME1 antibodies 
(Fig. 4C and D). Three immunoreactive bands, corresponding to 
monomeric, dimeric and much weaker, trimeric forms of CoAlated 
NME1 were detected in pulled-down samples from cells under metabolic 
stress (Fig. 4C). Extensive protein CoAlation is observed in total protein 
lysates of cells exposed to metabolic stress in comparison to control cells 
(Fig. 4D). Altogether, our findings demonstrate that NME1 CoAlation is 
induced in cellular response to oxidative stress and metabolic stress. 
3.5. Covalent and non-covalent binding of CoA to NME1 inhibits its 
NDPK activity 
The development of the in vitro CoAlation assay allowed us to study 
the impact of CoAlation on the activity of enzymes modified by covalent 
attachment of CoA, including Aurora kinase A (AurKA), creatine kinase 
(CK), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and perox-
iredoxin 5 (PRDX5) [31,35,40]. In most cases, the oxidative 
post-translational modification (oxPTM) of enzymes by CoA resulted in 
significant inhibition of their enzymatic activities. In this study, we 
explored the modulation of the NDPK activity of NME1 by covalent and 
non-covalent binding of CoA. 
To investigate the effect of CoAlation on NME1, the NDPK activity of 
reduced and in vitro CoAlated NME1 was assayed spectrophotometri-
cally. The assay involves three reactions: i) within the first reaction, 
NME1 transfers the phosphate of ATP to dCDP via its NDPK activity; ii) 
the ADP produced is then converted to ATP by pyruvate kinase. This 
reaction converts ADP and PEP into ATP and pyruvate; iii) finally, py-
ruvate is converted to lactate by PK in the presence of NADH. The latter 
reaction involves the consumption of NADH, which can be spectro-
photometrically monitored by following the decrease in A340 nm. CoAl-
ation of hNME1 significantly decreased the NME1 NDPK activity 
compared to the reduced hNME1 sample (Fig. 5A). These findings 
indicate that CoAlation negatively regulates the NDPK activity of 
hNME1. To determine whether the activity of NME1 could be restored 
following the removal of CoA, the CoAlated sample was incubated with 
DTT for 30 min at 25 ◦C before measuring its NDPK activity. The 
inhibitory effect of CoAlation on NDPK activity was nearly restored (to 
84.8%) upon removal of CoA in the presence of DTT. 
A C109A mutant of NME1 was recently shown to retain the NDPK 
activity under oxidative stress [7]. To demonstrate that Cys109 is the 
functional CoAlated residue which is affecting the NDPK activity, we 
generated the NME1 C109A mutant and showed that its NDPK activity 
was comparable to that of wild type (WT) hNME1. In vitro CoAlation of 
hNME1 C109A mutant had no effect on its NDPK activity (Fig. 5A). 
These findings further confirm the redox-sensitive nature of Cys109 in 
the regulation of the NDPK activity of NME1. 
Having demonstrated that NME1 can bind CoA (Fig. 1) and consid-
ering the structural similarities between ATP and CoA, we hypothesised 
that CoA could bind the nucleotide binding pocket and act as a 
competitive inhibitor. The NDPK activity of reduced hNME1 WT and 
C109A mutant was assayed in the presence of increasing concentrations 
of reduced CoA (0, 2, 4 mM) while the concentration of ATP used was 
kept constant at 2 mM. Fig. 5B demonstrates that CoA inhibits the NDPK 
activity of WT hNME1 (2 mM CoA- 43.3% inhibition; 4 mM CoA- 69.9% 
Fig. 4. NME1 CoAlation in mammalian cells is 
induced by oxidising agents and glucose depri-
vation. (A,B) Anti-CoA and anti-NME1 Western 
blot analyses of affinity purified transiently over-
expressed hNME1 from HEK293/Pank1β cells 
treated for 30 min with (A) 500 μM diamide, or (B) 
a dose-course of H2O2. (C) Anti-CoA and anti-NME1 
Western blot analyses of affinity purified transiently 
overexpressed hNME1 from HEK293/Pank1β cells 
subjected to 20 h-glucose deprivation (Gluc depr.). 
(D) Anti-CoA and anti-NME1 Western blot analyses 
of total protein CoAlation in HEK293/Pank1β cells 
glucose deprived for 20 h. Ponceau stain shows 
equal loading of samples. Monomers (M), dimers 
(D), trimers (T) or oligomers (O) of NME1 have 
been indicated. All figures shown are representative 
of at least three independent repeats. The anti- 
NME1 Western blots represent the respective 
amounts of NME1 purified from each sample for 
analysis (A–C).   
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inhibition). To further examine whether Cys109 influences the inhibi-
tion of NME1 by CoA, the same experiment was performed with the 
reduced form of NME1 C109A mutant (Fig. 5B). The results show that in 
the presence of CoA, the NDPK activity of C109A mutant is also inhibited 
(2 mM CoA- 22.1% inhibition; 4 mM CoA- 58.1%). Overall, we show that 
CoA decreases the NME1 NDPK activity in a CoAlation (disulfide linkage 
to cysteine) independent manner. This suggests that CoA has potentially 
two binding modes: i) covalently bound through Cys109 mixed disulfide 
bond (Fig. 5A) and ii) non-covalently bound to the nucleotide binding 
pocket (Fig. 5B). 
4. Discussion 
In this study, we show for the first time that CoA binds covalently and 
non-covalently to the metastasis suppressor NME1, and as a conse-
quence, negatively regulates its NDPK activity. Due to the structural 
homology provided by the ADP moiety of CoA, through non-covalent 
interactions, CoA could bind to the highly promiscuous nucleotide 
binding pocket of NME1, leading to the inhibition of its NDPK activity. 
When considering the mechanism and the relevance of CoA binding to 
NME1 within the context of cells, it is known that the concentration of 
ATP in the cytoplasm of mammalian cells ranges between 1 and 10 mM 
[47], which is approximately 100-fold higher than the cytoplasmic 
levels of CoA (0.014–0.14 mM) [21]. As ATP is more abundant in 
exponentially growing cells, it would outcompete CoA for the nucleotide 
binding pocket of NME1 and would act as a phosphate donor for the 
generation of other pools of NTPs via the NDPK activity. 
During oxidative or metabolic stress conditions, ATP levels could be 
eventually depleted [48,49] and hence, this would increase the proba-
bility of CoA to bind to NME1. The crystal structure of NME1 in complex 
with ADP [50] shows that Cys109 is buried within the Kpn-loop, which 
in turn interacts with the nucleotide. We therefore propose that due to 
thermal fluctuation or Cys4/Cys145 oxidation [6], the Kpn-loop could 
undergo a conformational change, leading to the exposure and subse-
quent oxidation of Cys109. It is at this stage that the formation of a 
mixed disulfide bond with the thiol group of CoA can occur. Subse-
quently, the 3′-phospho-ADP moiety of CoA is accommodated within the 
nucleotide binding pocket of NME1 (Fig. 5C). The structural rear-
rangements and functional implications of CoA binding to NME1 in 
physiological/pathophysiological conditions would be a topic of interest 
for future studies. 
Besides its extensively studied role in metastasis suppression, several 
studies have converged towards evidence that NME1 and NME2 are 
implicated in the regulation of oxidative stress response in different 
types of organisms. In Neurospora cressa and Arabidopsis thaliana (At) 
cells harbouring a kinase-defective mutant of an NME1 orthologue, 
NDK-1 (NDK-1P72H), show a decrease in catalase-1 and 3 (Cat-1 and Cat- 
3) levels, making them sensitive to oxidative, heat and light stress [51, 
52]. Furthermore, At-NDK-1 was found to directly interact with Cat-1. 
Cells overexpressing At-NDK-1 are shown to be more resilient against 
Fig. 5. CoAlation of hNME1 inhibits its NDPK 
activity. (A) Upon incubation with CoASSCoA, the 
NDPK activity of hNME1 WT is reduced by ~53%. 
In the presence of DTT, which reduces the mixed 
disulfide bond between CoA and hNME1, the NDPK 
activity is restored up to 84.8%. CoAlation of 
hNME1 C109A mutant shows no reduction in NDPK 
activity. In the absence of Cys109, CoAlation does 
not occur close to the active site and therefore, 
hNME1 maintains its NDPK activity. Data represent 
mean ± SEM from n = 2 or 3 experiments. p values 
were calculated using Šidák multiple comparison, 
ordinary one-way ANOVA test (****p < 0.0001, *p 
< 0.05, ns = not significant). (B) NDPK activity of 
hNME1 WT and C109A mutant was measured in the 
presence of increasing concentrations of reduced 
CoA (0, 2 and 4 mM). Results show that non- 
covalently bound CoA to both hNME1 WT and 
C109A mutant competitively inhibits their NDPK 
activity. The data are presented as a mean ± S.D. of 
at least three independent experiments. Data 
represent mean ± SEM from n = 2 or 3 experiments. 
p values were calculated using Šidák multiple 
comparison, ordinary one-way ANOVA test (****p 
< 0.0001, ***p < 0.0006). (C) Predictive model of 
CoA binding to NME1 under non-stressed and 
stressed cellular conditions. During non-stressed 
conditions, ATP binds to the active site of NME1 
in order to initiate its NDPK activity. However, 
under cellular stress conditions, CoA may poten-
tially bind non-covalently with its ADP moiety to 
the nucleotide-binding pocket of NME1; in this way, 
CoA may compete with ATP and other NTPs for the 
active site and possibly act as a competitive inhib-
itor for its NDPK activity. During oxidising condi-
tions, CoA can also form a mixed disulfide bond 
with Cys109. This is followed by the accommoda-
tion of the 3′-phospho-ADP moiety of CoA within 
the nucleotide binding pocket of NME1. Covalent 
anchoring of CoA onto NME1 would force NME1 
into an inactive state.   
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paraquat and H2O2 treatments [52]. NDK-2 has also been shown to 
regulate the cellular redox state by modulating the level of ROS in 
A. thaliana cells. NDK-2 is directly involved in enhancing the phos-
phorylation and activity of H2O2-activated MAPKs, indicating a role of 
NDK-2 in MAPK signalling in plants [53]. Moreover, in a mouse pro-B 
cell line (BAF3), NME1 and NME2 overexpression protect cells from 
H2O2-induced cell death [54]. NME1 deficiency was shown to sensitise 
primary human keratinocytes and mouse transformed hepatocytes to 
acute oxidative stress and impaired the activation of stress-activated 
protein kinases, JNK and MAPK, which are dependent on the NDPK 
activity of NME1 [55]. Increased sensitivity to acute paraquat 
mediated-oxidative stress was also observed in the liver of NME1 defi-
cient mice, which associated with decreased superoxide dismutase ac-
tivity and the overexpression of several stress-response genes, including 
glutathione transferases and glutathione reductase [55]. Interestingly, 
in human cervical cancer cell line HeLa, NME1 was shown to 
co-immunoprecipitate with p53. The overexpression of NME1 in these 
cells, upregulated the expression of p53 as well as a p53-regulated gene 
GPX1, which encodes for the antioxidant enzyme, glutathione peroxi-
dase 1, leading to increased cellular viability and resistance to oxidative 
stress [56]. These studies demonstrate that the involvement of NME1 
and NME2 in the oxidative stress response is conserved across different 
species, where both enzymes interact directly with stress response pro-
teins (e.g. catalase in plants and fungi) or indirectly as an upstream 
signal transducer of signalling pathways involved in stress response (e.g. 
MAPK pathways, JNK signalling and p53). From our findings that 
indicate NME1 and NME2 are major CoA-binding proteins in mamma-
lian cells and tissues, we speculate that CoA could be involved in the 
redox regulation of NME1 and NME2 activities (dependent on 
ATP/ADP:CoA ratio and the oxidative state of the cell), mediating the 
downstream stress response signalling pathways. 
While the importance of two-component histidine kinases in bacte-
ria, fungi and plants has long been recognised, very little is known about 
mammalian histidine kinases and histidine phosphatases due to the acid- 
labile nature of phosphohistidines, which are not detectable with 
commonly practised experimental techniques [57,58]. NME1,2,4 and 7 
have been shown to act as histidine kinases through autophosphor-
ylation on their active site histidine, followed by the transfer of the 
phosphoryl group to histidine residues on target proteins. Some known 
histidine phosphorylation targets of NMEs include, potassium channel 
KCa3.1 [59] and calcium channel TRPV5 [60] by NME2 and, aldolase C 
[61], ATP-citrate lyase [62], succinate thiokinase (succinyl-CoA syn-
thetase) [63] by NME1. The latter two enzymes are involved in CoA 
metabolism, where (i) ATP-citrate lyase catalyses the conversion of 
citrate to acetyl-CoA and links carbohydrate metabolism to fatty acid 
biosynthesis; and (ii) succinate thiokinase catalyses the reversible re-
action of succinyl-CoA to succinate. These may provide some insights 
into the relevance of CoA-binding to NME1 and its impact on the 
physiological/pathophysiological functions of NME1. 
5. Conclusion 
The findings presented in this study reveal NME1 as a novel CoA- 
binding partner. We report two modes of NME1 regulation by CoA: (i) 
through non-covalent interactions, capable of competing with ATP; and 
(ii) through covalent modification by forming mixed disulfide bonds 
with redox-sensitive cysteines. Our proposed model suggests that CoA 
binds to NME1 during cellular oxidative stress via a dual anchoring to 
Cys109 and then onto the nucleotide binding pocket of NME1, with its 
pantetheine thiol and ADP moiety, respectively (Fig. 5C). This study 
opens a novel avenue towards the exploration of NME1 regulation under 
oxidative or metabolic stress by an essential metabolic cofactor CoA, 
which has been recently found to function as a major cellular antioxi-
dant. NME1 is a moonlighting enzyme, which interacts with various 
binding partners (small and large GTPases, GDP-GTP exchange factor 
TIAM1, DNA repair and redox regulation transcriptional factor APAX1; 
pro-apoptotic protease granzyme A) to mediate important cellular pro-
cesses including maintaining intracellular nucleotide homeostasis, 
endocytosis, intracellular trafficking, stress-response signalling, cell 
motility and tumour metastasis [2,3]. Uncovering the role of CoA in the 
regulation of the diverse NME1 functions could help us understand 
further the involvement of CoA in cellular redox signalling and possibly 
in tumour metastasis. 
In addition to NME1, the MS-based analysis of CoAlated proteins in 
diamide-treated HEK293/Pank1β cells revealed over 20 CoA-modified 
kinases, that catalyse the transfer of phosphate groups from ATP to a 
diverse range of substrates. The list includes pyruvate kinase, mTOR 
kinase, creatine kinase, Aurora A kinase, pantothenate kinase, DNA-PK 
catalytic subunit and thymidylate kinase among others (Table S1). The 
mode of CoA binding and regulation of kinases with different substrate 
specificity in cellular response to oxidative and metabolic stress will be 
an interesting avenue for future studies. 
We have recently reported a novel mode of redox-regulated inhibi-
tion of Aurora A kinase by CoA, which locks the kinase in an inactive 
state via a “dual anchor” mechanism involving selective binding of the 
ADP moiety of CoA to the ATP binding pocket and covalent modification 
of Cys290 in the activation loop by the thiol group of the pantetheine tail 
[40]. In the large family of protein kinases, the cysteine residue in the 
activation loop is found in approximately 30% of kinases. They are 
predominantly surface-exposed, and therefore, may function as targets 
for redox modifications and signalling. Further bioinformatics analysis 
of CoAlation sites in protein kinases showed that cysteine CoAlation 
could also occur in other regulatory regions, which are distant from the 
ATP binding pocket and may involve a different mode of regulation. 
Indeed, we found a protein kinase which is allosterically activated by 
covalent CoA binding (unpublished data). Therefore, the 
redox-mediated regulation of kinases by CoA is an emerging and 
promising field of research. 
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catalysis and oligomeric structure in nucleoside diphosphate kinase, J. Biol. Chem. 
273 (8) (1998) 4436–4442. 
[6] M.S. Kim, J. Jeong, J. Jeong, D.H. Shin, K.J. Lee, Structure of Nm23-H1 under 
oxidative conditions, Acta Crystallogr D Biol Crystallogr 69 (Pt 4) (2013) 669–680. 
[7] E. Lee, J. Jeong, S.E. Kim, E.J. Song, S.W. Kang, K.J. Lee, Multiple functions of 
Nm23-H1 are regulated by oxido-reduction system, PloS One 4 (11) (2009), e7949. 
[8] K.H. Lin, W.J. Wang, Y.H. Wu, S.Y. Cheng, Activation of antimetastatic Nm23-H1 
gene expression by estrogen and its alpha-receptor, Endocrinology 143 (2) (2002) 
467–475. 
[9] K.M. Wong, J. Song, V. Saini, Y.H. Wong, Small molecules as drugs to upregulate 
metastasis suppressors in cancer cells, Curr. Med. Chem. 26 (32) (2019) 
5876–5899. 
[10] M.T. Hartsough, S.E. Clare, M. Mair, A.G. Elkahloun, D. Sgroi, C.K. Osborne, et al., 
Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and 
reduced motility by DNA methylation inhibition, Canc. Res. 61 (5) (2001) 
2320–2327. 
[11] W. Chen, S. Xiong, J. Li, X. Li, Y. Liu, C. Zou, et al., The ubiquitin E3 ligase SCF- 
FBXO24 recognizes deacetylated nucleoside diphosphate kinase A to enhance its 
degradation, Mol. Cell Biol. 35 (6) (2015) 1001–1013. 
[12] L.S. Fiore, S.S. Ganguly, J. Sledziona, M.L. Cibull, C. Wang, D.L. Richards, et al., C- 
Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 
metastasis suppressor in invasive cancer, Oncogene 33 (36) (2014) 4508–4520. 
[13] I. Khan, P.S. Steeg, Metastasis suppressors: functional pathways, Lab. Invest. 98 (2) 
(2018) 198–210. 
[14] A. Leone, U. Flatow, C.R. King, M.A. Sandeen, I.M.K. Margulies, L.A. Liotta, et al., 
Reduced tumor incidence, metastatic potential, and cytokine responsiveness of 
nm3-transfected melanoma cells, Cell 65 (1) (1991) 25–35. 
[15] D. Palmieri, C.E. Horak, J.-H. Lee, D.O. Halverson, P.S. Steeg, Translational 
approaches using metastasis suppressor genes, J. Bioenerg. Biomembr. 38 (3–4) 
(2006) 151–161. 
[16] M. Boissan, D. Wendum, S. Arnaud-Dabernat, A. Munier, M. Debray, I. Lascu, et al., 
Increased lung metastasis in transgenic NM23-null/SV40 mice with hepatocellular 
carcinoma, J. Natl. Cancer Inst. 97 (11) (2005) 836–845. 
[17] M. Boissan, O. De Wever, F. Lizarraga, D. Wendum, R. Poincloux, N. Chignard, et 
al., Implication of metastasis suppressor NM23-H1 in maintaining adherens 
junctions and limiting the invasive potential of human cancer cells, Canc. Res. 70 
(19) (2010) 7710–7722. 
[18] R. Leonardi, Y.M. Zhang, C.O. Rock, S. Jackowski, Coenzyme A: back in action, 
Prog. Lipid Res. 44 (2–3) (2005) 125–153. 
[19] F.L. Theodoulou, O.C.M. Sibon, S. Jackowski, I. Gout, Coenzyme A and its 
derivatives: renaissance of a textbook classic, Biochem. Soc. Trans. 42 (4) (2014) 
1025–1032. 
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[39] A. Zhyvoloup, B.Y.K. Yu, J. Baković, M. Davis-Lunn, M.A. Tossounian, N. Thomas, 
et al., Analysis of disulphide bond linkage between CoA and protein cysteine thiols 
during sporulation and in spores of Bacillus species, FEMS (Fed. Eur. Microbiol. 
Soc.) Microbiol. Lett. 367 (23) (2020). 
[40] Y. Tsuchiya, D.P. Byrne, S.G. Burgess, J. Bormann, J. Bakovic, Y. Huang, et al., 
Covalent Aurora A regulation by the metabolic integrator coenzyme A, Redox Biol 
28 (2020) 101318. 
[41] R.P. Agarwal, B. Robison, R.E. Parks Jr., Nucleoside diphosphokinase from human 
erythrocytes, Methods Enzymol. 51 (1978) 376–386. 
[42] E.H. Postel, C.A. Ferrone, Nucleoside diphosphate kinase enzyme activity of NM23- 
H2/PuF is not required for its DNA binding and in vitro transcriptional functions, 
J. Biol. Chem. 269 (12) (1994) 8627–8630. 
[43] J. Cox, M. Mann, MaxQuant enables high peptide identification rates, 
individualized p.p.b.-range mass accuracies and proteome-wide protein 
quantification, Nat. Biotechnol. 26 (12) (2008) 1367–1372. 
[44] C. Engel, R. Wierenga, The diverse world of coenzyme A binding proteins, Curr. 
Opin. Struct. Biol. 6 (6) (1996) 790–797. 
[45] D.H. Lundgren, S.I. Hwang, L. Wu, D.K. Han, Role of spectral counting in 
quantitative proteomics, Expert Rev. Proteomics 7 (1) (2010) 39–53. 
[46] P.S. Vieira, P.O. de Giuseppe, A.H.C. de Oliveira, M.T. Murakami, The role of the C- 
terminus and Kpn loop in the quaternary structure stability of nucleoside 
diphosphate kinase from Leishmania parasites, J. Struct. Biol. 192 (3) (2015) 
336–341. 
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